Switch or swap strategy in rheumatoid arthritis patients failing TNF inhibitors? Results of a modified Italian Expert Consensus-Reference-Cited by-同舟云学术

Switch or swap strategy in rheumatoid arthritis patients failing TNF inhibitors? Results of a modified Italian Expert Consensus

Published:2018-10-01 Issue:Supplement_7 Volume:57 Page:vii42-vii53
ISSN:1462-0324
Container-title:Rheumatology
language:en
Short-container-title:

Author:

Todoerti Monica¹,Favalli Ennio Giulio²,Iannone Florenzo³^ORCID,Olivieri Ignazio⁴,Benucci Maurizio⁵,Cauli Alberto⁶,Mathieu Alessandro⁶,Santo Leonardo⁷,Minisola Giovanni⁸,Lapadula Giovanni³,Bucci Romano⁹,Gremese Elisa¹⁰,Caporali Roberto¹^ORCID

Affiliation:

1. Division of Rheumatology, University of Pavia, IRCCS Policlinico San Matteo Foundation, Pavia

2. Department of Rheumatology, Gaetano Pini Institute, Milan

3. Department of Emergency and Organ Transplantation (DETO), University of Bari, Section of Rheumatology, Bari

4. Rheumatology Department of Lucania, San Carlo Hospital of Potenza and Madonna delle Grazie Hospital of Matera. Basilicata Ricerca Biomedica (BRB) Foundation, Potenza

5. Rheumatology Unit, S. Giovanni di Dio Hospital, Florence

6. Rheumatology Unit, University Clinic and AOU of Cagliari, Cagliari

7. Rheumatology Service ASL BT – DSS4 Barletta

8. Fondazione Ospedale San Camillo – Roma

9. Reumatologia Ospedaliera, Dipartimento Internistico, A.O.U. ‘OO.RR’ – Foggia

10. Institute of Rheumatology, Fondazione Policlinico Universitario Agostino Gemelli, Catholic University of the Sacred Heart, Rome, Italy

Publisher

Oxford University Press (OUP)

Subject

Pharmacology (medical),Rheumatology

Link

http://academic.oup.com/rheumatology/article-pdf/57/Supplement_7/vii42/25909504/key195.pdf

Reference43 articles.

1. TNF-alpha antagonist survival rate in a cohort of rheumatoid arthritis patients observed under conditions of standard clinical practice;Marchesoni;Ann N Y Acad Sci,2009

2. Recommendations for the use of biologic therapy in rheumatoid arthritis: update from the Italian Society for Rheumatology I. Efficacy;Caporali;Clin Exp Rheumatol,2011

3. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update;Smolen;Ann Rheum Dis,2014

4. 2015 American College of Rheumatology Guideline for the treatment of rheumatoid arthritis;Singh;Arthritis Care Res,2016

5. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update;Smolen;Ann Rheum Dis,2017

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identifying Predictors of First-Line Subcutaneous TNF-Inhibitor Persistence in Patients with Inflammatory Arthritis: A Decision Tree Analysis by Indication;Advances in Therapy;2023-08-11

2. Biological Agent Switching in Patients With Juvenile Idiopathic Arthritis;JCR: Journal of Clinical Rheumatology;2023-04-16

3. Management of patients with inflammatory rheumatic diseases after treatment failure with a first tumour necrosis factor inhibitor: A narrative review;Modern Rheumatology;2023-04-06

4. The second decade of anti-TNF-a therapy in clinical practice: new lessons and future directions in the COVID-19 era;Rheumatology International;2022-05-03

5. Neues zu Therapiestrategien bei der rheumatoiden Arthritis;Zeitschrift für Rheumatologie;2022-01-07